Table 2 Cost-effectiveness of IPTp-SP
Intervention costs/ DALYs averted in US$ for 2012 | Intervention | |
|---|---|---|
Results on clinical malaria [5] | 46.02 | IPTp-SP 2 doses vs Placebo |
Results on neonatal mortality [5] | 1.20 | IPTp-SP 2 doses vs Placebo |
Combined analysis for clinical malaria and neonatal mortality [5] | 1.13 | IPTp-SP 2 doses vs Placebo |
Combined analysis for clinical malaria, maternal anaemia and low birth weight [8] | 7.28 | IPTp-SP 3+ doses vs IPTp-SP 2 doses |